Guardant Health (GH) Gains from Investment Securities (2017 - 2026)

Guardant Health has disclosed Gains from Investment Securities across 10 years of filings, most recently posting $20.6 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $20.6 million, up 1292.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.3 million (up 478.5% YoY), and the FY2025 annual result was $869000.0, up 114.93% from the prior year.
• Gains from Investment Securities came in at $20.6 million for Q1 2026 at Guardant Health, up from $254000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $24.6 million in Q2 2025 to a low of -$22.3 million in Q3 2025.
• The 5-year median for Gains from Investment Securities is -$21000.0 (2022), against an average of $1.0 million.
• Across the five-year window, Gains from Investment Securities surged 51275.0% in 2022 and tumbled 2676.99% in 2024, its largest moves.
• Guardant Health's Gains from Investment Securities stood at -$4.2 million in 2022, then jumped by 154.63% to $2.3 million in 2023, then tumbled by 287.89% to -$4.3 million in 2024, then surged by 105.87% to $254000.0 in 2025, then surged by 8029.92% to $20.6 million in 2026.
• The last three Gains from Investment Securities figures came in at $20.6 million (Q1 2026), $254000.0 (Q4 2025), and -$22.3 million (Q3 2025), per Business Quant data.